Signal #151833 · SEC 8-K

$ELTX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ELTX filing catalyst

Why did $ELTX trigger an AI stock catalyst alert?

$ELTX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Elicio Therapeutics Reports Q3 2026 Net Loss of $8.0M vs $10.1M YoY, Cash Runway to Q2 2027. Key points: - Net loss improved to $8.0M ($0.30/share) from $10.1M ($0.60/share) in Q3 2025. - Cash and cash equivalents totaled $30.9M, providing runway into Q2 2027. - Phase 2 AMPLIFY-7P trial demonstrated reduced risk of recurrence/death (HR 0.47, p=0.0086).

How did $ELTX stock react after the SEC filing?

After the SEC 8-K for $ELTX, observed market reaction: T0 price $1.40. Past moves do not guarantee future results.

Where can I get real-time $ELTX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ELTX via Telegram and the VIP Web Terminal from €10/month.

$ELTX

$ELTX – Elicio Therapeutics Reports Q3 2026 Net Loss of $8.0M vs $10.1M YoY, Cash Runway to Q2 2027

Elicio Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $ELTX

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+3.0 / 10)

Net loss improved to $8.0M ($0.30/share) from $10.1M ($0.60/share) in Q3 2025.
Cash and cash equivalents totaled $30.9M, providing runway into Q2 2027.
Phase 2 AMPLIFY-7P trial demonstrated reduced risk of recurrence/death (HR 0.47, p=0.0086).

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →